Standard Chemical & Pharmaceutical Co., Ltd. manufactures and markets medicine for human and veterinary use, cosmetics, feeds and fertilizer.  In addition, the Company markets medical equipment and provides maintenance service.

Standard Chemical & Pharmaceutical (1720 TT)

The Board Approved An Investment In China And
Announced A Subsidiary'S Debt-To-Equity Conversion
Proposal.

Announcement Of Convening Scp
Investors’ Conference

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Standard Chemical & Pharmaceutical (1720 TT)

The Board Approved An Investment In China And Announced A Subsidiary'S Debt-To-Equity Conversion Proposal.

Announcement Of Convening Scp Investors’ Conference

Announcement Of The Board Approved Of The 2024q3 Consolidated Financial Statements

Announcement For The Expected Date Of The Board Of Directors Meeting For 2024 Third Quarter Financial Statements Is 2024/11/08

The Company Cooperated With The Ministry Of Justice Investigation Bureau'S Investigation As A Third Party.

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)